+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Biomedical Collagen Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Gelatin, Hydrolyzed Collagen, Native Collagen), By Source (Bovine, Porcine, Marine, Poultry, Plant-based), By Application (Medical Implants, Wound Dressings, Tissue Regeneration, Drug Delivery Systems, Cardiology, Bone & Joint Health) Companies, and Country Forecast, 2021 to 2034

Global Biomedical Collagen Market size is forecast to increase from $1.5 Billion in 2026 to $2.68 Billion in 2034 at a CAGR of 7.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005917
Pages: 223 Pages

Biomaterials Market Size, Share and Growth Outlook, 2026: Analysis By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), By Application (Orthopedics, Cardiovascular, Dental, Ophthalmology, Wound Healing, Tissue Engineering, Neurological, Plastic Surgery) Companies, and Country Forecast, 2021 to 2034

Global Biomaterials Market size is forecast to increase from $53.25 Billion in 2026 to $96.39 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005916
Pages: 221 Pages

Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Offering (Consumables, Services, Software), By Type (Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers), By Research Area (Genomics, Proteomics, Metabolomics, Other Research Areas), By Technology (Immunoassays, Polymerase Chain Reaction , Next-Generation Sequencing , Mass Spectrometry, Chromatography), By Application (Clinical Diagnostics, Drug Discovery & Development, Personalized Medicine, Clinical Research), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Biomarkers Market size is forecast to increase from $23.13 Billion in 2026 to $64.15 Billion in 2034 at a CAGR of 13.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005915
Pages: 226 Pages

Biomarker-based Immunoassays Market Size, Share and Growth Outlook, 2026: Analysis By Technology (CLIA , ELISA , FIA , Multiplex & Microarray Immunoassays, Lateral Flow Immunoassay ), By Product & Service (Reagents & Kits, Analyzers & Instruments, Software & Services), By Specimen Type (Blood & Serum, Saliva, Urine, Cerebrospinal Fluid ), By End-User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Point-of-Care) Companies, and Country Forecast, 2021 to 2034

Global Biomarker-based Immunoassays Market size is forecast to increase from $6 Billion in 2026 to $9.14 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005914
Pages: 213 Pages

Biomarker Testing Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Biomarker Research Services, Validation & Testing Services, Companion Diagnostics , Bioanalytical Services), By Disease Indication (Oncology, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Infectious Diseases), By End-User (Hospitals, Diagnostic Centers, Specialty Clinics, Pharmaceutical & Research Institutions), By Clinical Phase (Preclinical Phase, Clinical Phases , Post-Marketing Phase) Companies, and Country Forecast, 2021 to 2034

Global Biomarker Testing Services Market size is forecast to increase from $881.88 Million in 2026 to $1736.67 Million in 2034 at a CAGR of 8.84% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005913
Pages: 212 Pages

Biomarker Technologies Market Size, Share and Growth Outlook, 2026: Analysis By Technology Type (NGS , PCR , Mass Spectrometry, Chromatography, Imaging Technologies , Immunoassays), By Research Area (Genomics, Proteomics, Metabolomics, Lipidomics), By Application (Drug Discovery & Development, Clinical Diagnostics, Personalized Medicine, Clinical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Biomarker Technologies Market size is forecast to increase from $57 Billion in 2026 to $134.23 Billion in 2034 at a CAGR of 11.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005912
Pages: 214 Pages

Biomarker Discovery Outsourcing Services Market Size, Share and Growth Outlook, 2026: Analysis By Type of Biomarker (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints), By Technology (Genomics, Proteomics, Bioinformatics, Metabolomics), By Discovery Phase (Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development), By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), By End-User (Pharmaceutical Companies, Biotechnology Companies) Companies, and Country Forecast, 2021 to 2034

Global Biomarker Discovery Outsourcing Services Market size is forecast to increase from $22.49 Billion in 2026 to $92.28 Billion in 2034 at a CAGR of 19.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005911
Pages: 219 Pages

Biomarker Clinical Phase Outsourcing Services Market Size, Share and Growth Outlook, 2026: Analysis By Service Type (Biomarker Validation Services, Assay Development & Monitoring, Bioanalytical Services, Clinical Data Management), By Clinical Phase (Phase I, Phase II, Phase III, Phase IV ), By Therapeutic Area (Oncology, Neurology, Cardiology, Immunology & Inflammatory Diseases, Rare Diseases), By End-User (Biopharmaceutical Companies, Medical Device Companies, Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Biomarker Clinical Phase Outsourcing Services Market size is forecast to increase from $12.22 Billion in 2026 to $48.81 Billion in 2034 at a CAGR of 18.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005910
Pages: 228 Pages

Biologics Safety Testing Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Services , Consumables , Instruments), By Test Type (Endotoxin Tests, Sterility Tests, Mycoplasma Tests, Bioburden Tests, Viral Safety Tests, Residual Host-Cell Protein and DNA Detection Tests), By Application (Monoclonal Antibodies , Vaccines Development & Manufacturing, Cellular and Gene Therapy Products, Blood & Blood Products), By End-User (Pharmaceutical & Biotechnology Companies, Contract Development and Manufacturing Organizations , Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Biologics Safety Testing Market size is forecast to increase from $5.35 Billion in 2026 to $12.87 Billion in 2034 at a CAGR of 11.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005909
Pages: 227 Pages

Biologics Regulatory Affairs Outsourcing Market Size, Share and Growth Outlook, 2026: Analysis By Stage of Development (Pre-clinical Regulatory Support, Clinical Trial Regulatory Operations, Post-Marketing ), By Service Type (Regulatory Writing and Document Submission, Regulatory Strategy and Strategic Consulting, Legal Representation and Product Registration Services, Pharmacovigilance and Post-Market Surveillance Support), By Target Product Category (Novel Biologics , Biosimilars and Biobetters, Advanced Therapy Medicinal Products ), By End-User Size (Tier 1 , Tier 2 , Small-scale Biotech and Startup Operations) Companies, and Country Forecast, 2021 to 2034

Global Biologics Regulatory Affairs Outsourcing Market size is forecast to increase from $2.91 Billion in 2026 to $5.88 Billion in 2034 at a CAGR of 9.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005908
Pages: 227 Pages